[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: ALARA Cost/Benefit
- To: SMTP PMDFADDR <MAILGATE@ADDRMELON.CA.boeing.com>
- Subject: Re: ALARA Cost/Benefit
- From: Bruce Pickett <SHEA136@KGV2.bems.boeing.com>
- Date: Fri, 18 Oct 1996 12:07:10 -0700 (PDT)
- Alternate-Recipient: prohibited
- Disclose-Recipients: prohibited
- Hop-Count: 0
- Importance: normal
- Mr-Received: by mta MELON; Relayed; Fri, 18 Oct 1996 12:07:09 -0700
- Priority: normal
- Resent-Date: Fri, 18 Oct 1996 12:12:42 -0700
- Resent-From: SHEA136@KGV2.bems.boeing.com
- Resent-Message-Id: <9610190154.AA03230@atc.boeing.com>
- Resent-To: radsafe@romulus.ehs.uiuc.edu
- Ua-Content-Id: Re: ALARA Cost/Benefit
- X400-Mts-Identifier: [;MRP$18OCT199612070952]
Is this figure ($2000) specific to a particular activity such as power
production, or does it apply across the board to all regulated activities,
including nuclear medicine, industrial radiography, etc.?
Larry Proud
The Boeing Company, Seattle, WA
lawrence.a.proud@boeing.com
>See NUREG -1530, "Reassessment of NRC's Dollar per Person-Rem Conversion
>Factor Policy." In it the NRC has decided to adopt a $2000 per person-rem
>conversion factor subject to present worth considerations, and limit its
>scope soley to health effects. This in contrast to its earlier policy of
>an undiscounted $1000 per person-rem conversion factor that served as a
>surrogate for all offsite consequences.
>>I am looking for some suggested figures to use in an ALARA cost/benefit
>>analysis in terms of $ expended per Rem (or Sievert) saved. Any
>>thoughts on this would be appreciated.